Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer

Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer

Understanding PIRA in MS: An Overview with Dr. Barry Singer

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

The pathophysiology of ITP stems from complex immune dysregulation drives thrombocytopenia and inflammation

Rilzabrutinib a BTK inhibitor

Complex immune dysregulation impact on QoL

Interplay between the innate and adaptive immunity

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Early Intervention and Disease Modification in Atopic Dermatitis

TTP Patient Case Study in Kuwait

Dr. Huda Al Sahaaf discusses her experience with a 48-years-old male patient, underscoring the urgency and severe consequences of TTP when signs go unnoticed the importance of initiating aTTP treatment promptly an aTTP episode.

Effective Treatment Simplification

Prof. Robert Ritzel, Division of Endocrinology, Munich and University of Heidelberg, Germany, presents effective treatment simplification for people with T2D using fixed ration combination of iGlarLixi.